Fresenius Medical Care stock faces November 3 results date
Fresenius Medical Care's next quarterly results are scheduled for November 3, 2026, according to the company's investor ...
Analysis updated on Oct. 16, 2026 (UTC) · Total · absolute moveSwitch to Alpha · NYSE
Our AI ranks Fresenius Medical Care Ag outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
Fresenius Medical Care Ag is a large-cap company with a market capitalization of $12.85B. It ranks number 1 by market capitalization among the 13 Services-Misc Health & Allied Services, NEC issuers in our coverage with a current forecast.
For FMS, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 23.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 28.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected absolute price move over the horizon, market included. This is the number a price target is built from. Ratings: strong buy ≥ +5.0%, buy ≥ +3.4%, sell < +1.8%, strong sell < +0.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-16 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, FMS included.
Follow FMS free90D Total forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Services-Misc Health & Allied Services, NEC peers listed below that report each metric.
| Metric | FMS | Rank |
|---|---|---|
| Market Cap | $12.85B | 1/13 |
| Revenue/Share | $58.96 | – |
| Metric | FMS | Rank |
|---|---|---|
| ROE | 12.2% | 3/7 |
| Net Margin | 4.8% | 6/10 |
| Metric | FMS | Rank |
|---|---|---|
| D/E Ratio | 1.26x | 4/10 |
| Interest Coverage | 7.4x | 4/12 |
| Metric | FMS | Rank |
|---|---|---|
| Total Revenue | $34.19B | 1/10 |
| Net Income | $1.63B | 1/10 |
| Metric | FMS | Rank |
|---|---|---|
| Shares Outstanding | 580M | – |
| Net Income Growth | 61.5% | 2/6 |
| Total Liabilities | $16.72B |
Companies classified under the same SEC industry code as Fresenius Medical Care Ag (Services-Misc Health & Allied Services, NEC): 13 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Total) | Market Cap |
|---|---|---|
| FMS Fresenius Medical Care Ag | ▼ | $12.85B |
| DVA Davita Inc. | ▶ | $11.95B |
| SHC Sotera Health Co | ▼ | $5.11B |
| PGNY Progyny, Inc. | ▼ | $2.06B |
| AGL Agilon Health, Inc. | ▲ | $1.43B |
| VMD Viemed Healthcare, Inc. | ▼ | $361M |
| PARK Park Dental Partners, Inc. | ▲ | $91M |
| MRAI Marpai, Inc. | ▲ | $85M |
| CCEL Cryo Cell International Inc | ▲ | $36M |
| PFHO Pacific Health Care Organization Inc | ▶ | $12M |
| MGRX Mangoceuticals, Inc. | ▲ | $7M |
| NIVF Newgenivf Group Ltd | ▼ | $2M |
| BRTX Biorestorative Therapies, Inc. | ▼ | $2M |
Fresenius Medical Care's next quarterly results are scheduled for November 3, 2026, according to the company's investor ...
Ariel Investments, an investment management company, released its "Ariel Global Fund" fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. Ariel Global Fund delivered ...
Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, ...
Our AI ranks Fresenius Medical Care Ag outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
For FMS, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 23.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 28.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Fresenius Medical Care Ag forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 16, 2026.
13 issuers in our coverage, FMS included, share the SEC industry code Services-Misc Health & Allied Services, NEC. The largest are: Davita Inc. (DVA), Sotera Health Co (SHC), Progyny, Inc. (PGNY), Agilon Health, Inc. (AGL), Viemed Healthcare, Inc. (VMD), Park Dental Partners, Inc. (PARK).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.
Signals, companies, plans: answered from live data.
I read Intratio's daily model signals, company data and your account to answer in seconds, in your language.